<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02601482</url>
  </required_header>
  <id_info>
    <org_study_id>H-15008542 - 2</org_study_id>
    <nct_id>NCT02601482</nct_id>
  </id_info>
  <brief_title>Optimization of Interval-training in Patients With Type 2 Diabetes</brief_title>
  <official_title>Optimization of Interval-training in Patients With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single bout of Interval-Walking (IW) exercise is superior to energy-expenditure and
      time-duration matched Continuous Walking (CW) exercise upon improving glycemic control. The
      time spend with high-intensity (fast) walking is considered to be responsible for the
      improvements seen, whereas the time spend with low-intensity (slow) walking is considered
      less important.

      This study will assess if IW with maintained fast walking time duration but reduced total
      time duration (i.e. reduced slow walking time duration) is equally effective as IW with a
      normal time duration.

      Subjects with type 2 diabetes will be included in a crossover, controlled study, where each
      subject will undergo three trials. Trials will be identical except the following
      interventions:

        1. Sixty minutes of rest (CON)

        2. Sixty minutes of classical interval walking (repeated cycles of 3 minutes of fast and 3
           minutes of slow walking; IW-60)

        3. Fourty-five minutes of time-reduced interval walking (repeated cycles of 3 minutes of
           fast and 1.5 minutes of slow walking; IW-45).

      After the interventions subjects will undergo a standardized mixed meal tolerance test with
      assessment of glycemic control.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>Within the first 4 hours after the intervention</time_frame>
    <description>Glycemic control will be assessed after each intervention. Subjects will receive a standardized mixed meal tolerance test (MMTT), and blood glucose values will be obtained during the test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Matsuda insulin sensitivity index</measure>
    <time_frame>Within the first 4 hours after the intervention</time_frame>
    <description>From the measurements of glucose and insulin during the MMTT, the Matsuda index of insulin sensitivity will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stumvoll insulin sensitivity index</measure>
    <time_frame>Within the first 4 hours after the intervention</time_frame>
    <description>From the measurements of glucose and insulin during the MMTT, the Stumvoll index of insulin sensitivity will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cederholm insulin sensitivity index</measure>
    <time_frame>Within the first 4 hours after the intervention</time_frame>
    <description>From the measurements of glucose and insulin during the MMTT, the Cederholm index of insulin sensitivity will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HOMA-2 insulin resistance index</measure>
    <time_frame>Within the first 4 hours after the intervention</time_frame>
    <description>From the measurements of glucose and insulin during the MMTT, the HOMA-2 index of insulin resistance will be assessed.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Control (CON)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No exercise intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Interval Walking (IW-60).</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sixty minutes with repeated cycles of 3 minutes of fast and 3 minutes of slow walking on a treadmill</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Time-reduced Interval Walking (IW-45)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Forty-five minutes with repeated cycles of 3 minutes of fast and 1.5 minutes of slow walking on a treadmill</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CON</intervention_name>
    <arm_group_label>Control (CON)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>IW-60</intervention_name>
    <arm_group_label>Normal Interval Walking (IW-60).</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>IW-45</intervention_name>
    <arm_group_label>Time-reduced Interval Walking (IW-45)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 Diabetes Mellitus

          -  BMI &gt; 25

        Exclusion Criteria:

          -  Pregnancy

          -  Smoking

          -  Contraindication to increased levels of physical activity

          -  Eating disorder

          -  Insulin dependence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Center for Physical Activity Research (CFAS)</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2015</study_first_submitted>
  <study_first_submitted_qc>November 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2015</study_first_posted>
  <last_update_submitted>June 21, 2016</last_update_submitted>
  <last_update_submitted_qc>June 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Anders Rasmussen Rinnov</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Glycemic control</keyword>
  <keyword>exercise</keyword>
  <keyword>Interval Training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

